Summary
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Kisspeptin is more often discussed in the realm of Reproductive health, whereas Sermorelin is more often associated with the realm of Metabolic and endocrine and Aging and longevity. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Kisspeptin leaning toward and Sermorelin leaning toward Anabolic growth and Lipolysis and fat loss. Kisspeptin has a more natural endogenous origin, while Sermorelin is closer to synthetic analog background and their development context also differs, with Kisspeptin in Preclinical development while Sermorelin is approved. They are also usually discussed through the same administration routes, namely subcutaneous injection and intravenous infusion.